Log in

NYSE:BCSFBain Capital Specialty Finance Stock Price, Forecast & News

$10.52
+0.22 (+2.14 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.39
Now: $10.52
$10.84
50-Day Range
$9.48
MA: $10.63
$12.15
52-Week Range
$7.11
Now: $10.52
$20.35
Volume282,050 shs
Average Volume201,607 shs
Market Capitalization$543.36 million
P/E RatioN/A
Dividend Yield15.92%
Beta1.5
Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 1.8Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.42 out of 5 stars


Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone617-516-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$197.95 million
Cash Flow$1.62 per share
Book Value$19.72 per share

Profitability

Net Income$98.08 million

Miscellaneous

EmployeesN/A
Market Cap$543.36 million
Next Earnings DateN/A
OptionableNot Optionable
$10.52
+0.22 (+2.14 %)
(As of 08/6/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BCSF News and Ratings via Email

Sign-up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bain Capital Specialty Finance (NYSE:BCSF) Frequently Asked Questions

How has Bain Capital Specialty Finance's stock been impacted by COVID-19 (Coronavirus)?

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BCSF stock has decreased by 37.5% and is now trading at $10.52.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Bain Capital Specialty Finance?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bain Capital Specialty Finance
.

How were Bain Capital Specialty Finance's earnings last quarter?

Bain Capital Specialty Finance Inc (NYSE:BCSF) posted its quarterly earnings results on Wednesday, August, 5th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.37. Bain Capital Specialty Finance had a negative net margin of 21.80% and a positive return on equity of 8.72%.
View Bain Capital Specialty Finance's earnings history
.

How often does Bain Capital Specialty Finance pay dividends? What is the dividend yield for Bain Capital Specialty Finance?

Bain Capital Specialty Finance declared a quarterly dividend on Monday, May 4th. Investors of record on Tuesday, June 30th will be given a dividend of $0.41 per share on Thursday, July 30th. This represents a $1.64 annualized dividend and a dividend yield of 15.59%. The ex-dividend date of this dividend is Monday, June 29th.
View Bain Capital Specialty Finance's dividend history
.

What price target have analysts set for BCSF?

8 Wall Street analysts have issued 1-year price targets for Bain Capital Specialty Finance's stock. Their forecasts range from $7.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's share price to reach $12.14 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price.
View analysts' price targets for Bain Capital Specialty Finance
.

Has Bain Capital Specialty Finance been receiving favorable news coverage?

News coverage about BCSF stock has trended positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bain Capital Specialty Finance earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about Bain Capital Specialty Finance
.

Who are some of Bain Capital Specialty Finance's key competitors?

What other stocks do shareholders of Bain Capital Specialty Finance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Altria Group (MO), Pfizer (PFE), AT&T (T), Alibaba Group (BABA), Cisco Systems (CSCO) and Walt Disney (DIS).

Who are Bain Capital Specialty Finance's key executives?

Bain Capital Specialty Finance's management team includes the following people:
  • Mr. Michael Alexander Ewald, Pres, CEO & Director (Age 45)
  • Ms. Sally Fassler Dornaus CPA, CPA, Chief Financial Officer (Age 44)
  • Mr. Derek Kirby, Investor Contact
  • Mr. James Goldman, Chief Compliance Officer (Age 42)
  • Mr. James S. Athanasoulas, VP & Treasurer (Age 45)

When did Bain Capital Specialty Finance IPO?

(BCSF) raised $156 million in an initial public offering (IPO) on Thursday, November 15th 2018. The company issued 7,500,000 shares at $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

What is Bain Capital Specialty Finance's stock symbol?

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Who are Bain Capital Specialty Finance's major shareholders?

Bain Capital Specialty Finance's stock is owned by a variety of institutional and retail investors. Top institutional investors include UBS Group AG (3.31%), Starr International Co. Inc. (1.43%), Sumitomo Mitsui Trust Holdings Inc. (0.88%), C.V. Starr & Co. Inc. Trust (0.74%), Beaumont Financial Partners LLC (0.52%) and Raymond James Financial Services Advisors Inc. (0.20%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance
.

Which institutional investors are selling Bain Capital Specialty Finance stock?

BCSF stock was sold by a variety of institutional investors in the last quarter, including Parallel Advisors LLC, Virtus ETF Advisers LLC, Mission Wealth Management LP, Texas Yale Capital Corp., FCG Advisors LLC, JNB Advisors LLC, and CFO4Life Group LLC.
View insider buying and selling activity for Bain Capital Specialty Finance
.

Which institutional investors are buying Bain Capital Specialty Finance stock?

BCSF stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Sumitomo Mitsui Trust Holdings Inc., Mckinley Capital Management LLC Delaware, Meridian Investment Counsel Inc., Mount Yale Investment Advisors LLC, C.V. Starr & Co. Inc. Trust, Starr International Co. Inc., and Beaumont Financial Partners LLC. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance
.

How do I buy shares of Bain Capital Specialty Finance?

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bain Capital Specialty Finance's stock price today?

One share of BCSF stock can currently be purchased for approximately $10.52.

How big of a company is Bain Capital Specialty Finance?

Bain Capital Specialty Finance has a market capitalization of $543.36 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

What is Bain Capital Specialty Finance's official website?

The official website for Bain Capital Specialty Finance is www.baincapital.com.

How can I contact Bain Capital Specialty Finance?

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.